MSc by Research Regenerative Medicine and Tissue Repair

Engineered macrophages boost blood cell production

Scientists at CRM have engineered macrophages in the laboratory from stem cells.

Scientists at the MRC Centre for Regenerative Medicine have been able to engineer specialised immune cells known as macrophages in the laboratory from stem cells. 

Macrophages are specialist cells that support the immune defences of the human body and can support the growth and repair of damaged organs.  One specialist type of macrophage supports the production of red blood cells in the bone marrow.

The team genetically modified stem cells in which a single gene, called KLF1, could be switched on. When the gene was switched on the team were able to produce macrophages that could support red blood cell production.

Until now it has not been possible to mimic the cell environment that supports red blood cell production. This is the first time scientists have been able to do this in the lab and it allows them to study the precise details of the process. 

Further investigation of the genes that were switched on or off by KLF1 in macrophages identified three cell products which are important for red cell production. Addition of these factors in combination increased red cell production in the absence of macrophages.

Although this improves red blood cell production in the lab, the team emphasise that we are still a long way from producing enough blood of the right quality for blood transfusions. More significantly, they say, the ability to manipulate macrophages in this way could allow the production of immune cells which could help repair damaged tissue in the human body. Professor Lesley Forrester, who led the team of scientists said,

This work is really exciting because it demonstrates that we can generate a specific type of macrophage in the laboratory.  In this study we make macrophages that improve blood cell production but it could be adapted to make macrophages that do other jobs in the body such as repairing damaged tissue.

Prof Lesley ForresterProfessor of Stem Cell Differentiation at CRM; Postgraduate Director CRM

The study was funded by the Wellcome Trust, CONACYT, Medical Research Council and COST Action BM1404 Mye-EUNITER. It is published in Nature Communications.The paper can be accessed via the link below.

Lopez-Yrigoyen et al (2019). Genetic programming of macrophages generates an in vitro model for the human erythroid island niche. Nature Comm 10:881